Entering text into the input field will update the search result below

ReShape Lifesciences' (RSLS) CEO Dan Gladney on Q4 2017 Results - Earnings Call Transcript

Apr. 02, 2018 10:59 PM ETReShape Lifesciences Inc. (RSLS)
SA Transcripts profile picture
SA Transcripts

ReShape Lifesciences Inc. (NASDAQ:RSLS) Q4 2017 Earnings Conference Call April 2, 2018 4:30 PM ET


Dan Gladney - Chairman & CEO

Scott Youngstrom - CFO



Good day, ladies and gentlemen and thank you for standing by. Welcome to the ReShape Lifesciences Fourth Quarter and 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following managements prepared remarks, we will host a question-and-answer session, and instructions will be given at that time. [Operator Instructions] As a reminder, this conference call is being recorded for reply purposes.

It is now pleasure to hand the conference over to Mr. Scott Youngstrom, Chief Financial Officer. Sir, you may begin.

Scott Youngstrom

Thank you. Good afternoon and thank you for joining us on today's call. I am pleased to be joined by Dan Gladney, our President, CEO and Chairman of the Board; who will provide an overview of the Company's recent activities and business highlights. I will then review our financial results for the fourth quarter and full year 2017. After that, Dan will wrap up and following our remarks, we will be available for questions during the Q&A session.

As a reminder, this conference call as well as ReShape Lifesciences SEC filings and website at www.reshapelifesciences.com, including the investor information section of the website contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our actual results could differ materially from those discussed due to the known and unknown risks, uncertainties and other factors. These and additional risks and uncertainties are described more fully in the Company's filings with the Securities Exchange Commission, including those factors identified as Risk Factors in our annual report on Form 10-K filed earlier this afternoon.

As an additional reminder, our stock is still listed on NASDAQ

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.